I have never disputed that Omontys is "not inferior" to Epogen/Aranesp in terms of efficacy. It is the safety profiles and actual patient usage adverse events that prove Omontys is unsafe compared to the industry standard regimen. Please explain how the BOD is liable for breach of fiduciary duty to declare bankruptcy where there is a failed drug, no revenues, ongoing expenses and crushing litigation. I really would like to understand your reasoning.
Yay! DOYO has apparently survived the AFFY Train Wreck and lived to tell the story.
I will say this for LaffyStock Longs. They do not go down without fighting. Besides Ramm - who is wise - nobody else has thrown in the towel, saved some money, used this as a learning experience and moved on. Everyone else is going down with the ship, or train, as it were. It makes for a compelling last chapter to the LAFFY saga. Thank you indeed.
Before it is over you you bashers will be chasing the pps trying to buy back in, mark this post!!!! If you would wise up and think about it, the Longs here have educated you more than once and disproved all of your lies, try to see the forest before it is too late.